The National Health Surveillance Agency approved the first generic semaglutide pen in Brazil. The generic medication was produced by Brazilian company EMS.
With this approval, the number of semaglutide-based medications approved in Brazil reached nine, all obtained in a period of less than six months.
Semaglutide is a medication widely used in the treatment of type 2 diabetes and also indicated for weight loss in certain cases.



